11-16

10-29
SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine
10-24
In the post-epidemic era of the blue ocean market--POC, Screen, Home Testing,Nanjing Synthgene Medical accelerates product line distribution!
10-19
New Product Launch SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit(Colloidal gold method)—Lollipop style
10-12
SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical enters the whitelist of French COVID-19 detection products
10-08
Nanjing Synthgene Medical COVID -19 Antigen detection kit passed the laboratory test of Mahidol University in Thailand
05-13
Analysis on the situation of pharmaceutical foreign trade in the first quarter of 2011
05-13
The United States Pharmacopeia publishes new heparin quality standards
Contact Us
Address:Building B6-2, No. 9, Weidi Road, Xianlin University Town, Xianlin Subdistrict, Qixia District, Nanjing City, China
Tel: +86(025)83696681 (overseas)
Email:sales@syngenebio.com
After-sale Email :service@syngenebio.com

Public Account
Copyright © Nanjing Synthgene Medical Technology Co., Ltd. 苏ICP备19039931号-1 Powered by:www.300.cn


